Euripedes Gomes de Carvalho Neto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Euripedes Gomes de Carvalho Neto has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Roberto Mello Rieder
Universidade Federal de Ciências da Saúde de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil
7 shared publications - Matheus Ferreira Gomes
From the Irmandade Santa Casa de Misericórdia de Porto Alegre, Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
6 shared publications - Mateus Damiani Monteiro
Department of Neurology, Hospital São João Batista, Criciúma, Brazil; and
4 shared publications Ana Maria Hoppe
From the Irmandade Santa Casa de Misericórdia de Porto Alegre, Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
3 shared publicationsFrancisco Tellechea Rotta
From the Irmandade Santa Casa de Misericórdia de Porto Alegre, Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
3 shared publicationsIuri Pereira dos Santos
From the Irmandade Santa Casa de Misericórdia de Porto Alegre, Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
3 shared publications
Latest Publications
- 13 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (7)
Teaching NeuroImage: Mees Lines as a Clinical Clue to Arsenic Poisoning
- 13 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (7)
Teaching NeuroImage: Mees Lines as a Clinical Clue to Arsenic Poisoning
- Open Access
- 13 August 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (11) , 001-005
The whistle-smile reflex in Parkinson's disease: an exploratory case-control study
Parkinson's disease (PD) is a well-known neurodegenerative disease characterized by tremors, rigidity, and bradykinesia. In 1943, Frederic Hanes described the whistle-smile reflex (WSR), noting its absence in PD patients due to reduced facial movements. To assess the WSR's diagnostic performance. In the current cross-sectional study, we selected PD patients and healthy controls. They were filmed while asked to whistle, and a blinded physician assessed if the individuals smiled or not. Absence of smiling after whistling was considered a positive test. We stratified the smiling intensity into 4 groups. We calculated the odds ratio (OR) of the positive WSR in PD and asymptomatic patients, which was reported with CIs, sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and we plotted a receiver operating characteristic (ROC) curve. We identified 43 patients with PD (mean age = 63 ± 10 years; 30% of female subjects) and 44 asymptomatic controls (mean age = 64 ± 10 years; 51% of female subjects). The WSR test was positive in 35/43 PD cases versus 7/44 in the asymptomatic group (OR = 23.1; 95%CI = 7.6–70.5; SE = 81.4%; SP = 84.1%; PPV = 83.3%; NPV = 82.2%). When stratified considering the group with the least intense smile as a positive test, the test was positive in 42/43 PD cases versus 23/44 in the asymptomatic group (OR = 38.3; 95%CI = 4.8–303.7; SE = 97.7%; SP = 47.7%; PPV = 64.6%; NPV = 95.4%). The WSR test showed a good performance in identifying PD patients; it may complement the physical examination, and its result may be a useful finding during the assessment of a patient with PD.
- 13 August 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (11) , 001-005
Open AccessThe whistle-smile reflex in Parkinson's disease: an exploratory case-control study
Parkinson's disease (PD) is a well-known neurodegenerative disease characterized by tremors, rigidity, and bradykinesia. In 1943, Frederic Hanes described the whistle-smile reflex (WSR), noting its absence in PD patients due to reduced facial movements. To assess the WSR's diagnostic performance. In the current cross-sectional study, we selected PD patients and healthy controls. They were filmed while asked to whistle, and a blinded physician assessed if the individuals smiled or not. Absence of smiling after whistling was considered a positive test. We stratified the smiling intensity into 4 groups. We calculated the odds ratio (OR) of the positive WSR in PD and asymptomatic patients, which was reported with CIs, sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and we plotted a receiver operating characteristic (ROC) curve. We identified 43 patients with PD (mean age = 63 ± 10 years; 30% of female subjects) and 44 asymptomatic controls (mean age = 64 ± 10 years; 51% of female subjects). The WSR test was positive in 35/43 PD cases versus 7/44 in the asymptomatic group (OR = 23.1; 95%CI = 7.6–70.5; SE = 81.4%; SP = 84.1%; PPV = 83.3%; NPV = 82.2%). When stratified considering the group with the least intense smile as a positive test, the test was positive in 42/43 PD cases versus 23/44 in the asymptomatic group (OR = 38.3; 95%CI = 4.8–303.7; SE = 97.7%; SP = 47.7%; PPV = 64.6%; NPV = 95.4%). The WSR test showed a good performance in identifying PD patients; it may complement the physical examination, and its result may be a useful finding during the assessment of a patient with PD.
- 3 May 2026
- Published by Taylor & Francis in Immunotherapy
- Vol. 18 (7) , 559-566
Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature review
1. Autoimmune encephalitis (AE) is an inflammatory disease of the brain with diverse etiologies, making diagnosis challenging due to its wide range of clinical manifestations [1]. It typically pres...
- 3 May 2026
- Published by Taylor & Francis in Immunotherapy
- Vol. 18 (7) , 559-566
Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature review
1. Autoimmune encephalitis (AE) is an inflammatory disease of the brain with diverse etiologies, making diagnosis challenging due to its wide range of clinical manifestations [1]. It typically pres...
- Open Access
- 23 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (04) , 001-008
Prevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients
Impulse control disorders (ICDs) are potentially serious complications of Parkinson's disease (PD). Treatment, particularly the use of dopamine agonists (DAs), is associated with the development of ICDs and related behaviors. However, susceptibility to these disorders appears to be linked to specific risk factors. To assess the frequency, clinical presentation, and factors associated with the development of ICDs in a population of patients with PD. Patients with PD were screened for ICD-related symptoms using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson''s Disease -Current Short (QUIP-CS) questionnaire. Additionally, they underwent cognitive evaluation and were assessed using the Movement Disorder Society–Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Sociodemographic data and disease progression information were collected. Levodopa equivalent daily dose (LEDD) was calculated for each patient. Of the 90 patients evaluated, 42 (46.6%) exhibited symptoms of ICDs. The most frequent subtype was binge eating (50%), followed by compulsive buying (33.3%) and hypersexuality (21.4%). A significant association was found between DA use and the development of ICDs (p = 0.041). Patients with ICDs using DAs had a higher mean LEDD (p < 0.001) and a higher frequency of motor complications (MDS-UPDRS Part IV, p = 0.028) compared to those not using DAs. In the current study, the use of DAs was the main risk factor associated with the development of impulse control disorders. No other significant associated factors could be identified.
- 23 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (04) , 001-008
Open AccessPrevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients
Impulse control disorders (ICDs) are potentially serious complications of Parkinson's disease (PD). Treatment, particularly the use of dopamine agonists (DAs), is associated with the development of ICDs and related behaviors. However, susceptibility to these disorders appears to be linked to specific risk factors. To assess the frequency, clinical presentation, and factors associated with the development of ICDs in a population of patients with PD. Patients with PD were screened for ICD-related symptoms using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson''s Disease -Current Short (QUIP-CS) questionnaire. Additionally, they underwent cognitive evaluation and were assessed using the Movement Disorder Society–Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Sociodemographic data and disease progression information were collected. Levodopa equivalent daily dose (LEDD) was calculated for each patient. Of the 90 patients evaluated, 42 (46.6%) exhibited symptoms of ICDs. The most frequent subtype was binge eating (50%), followed by compulsive buying (33.3%) and hypersexuality (21.4%). A significant association was found between DA use and the development of ICDs (p = 0.041). Patients with ICDs using DAs had a higher mean LEDD (p < 0.001) and a higher frequency of motor complications (MDS-UPDRS Part IV, p = 0.028) compared to those not using DAs. In the current study, the use of DAs was the main risk factor associated with the development of impulse control disorders. No other significant associated factors could be identified.
- 18 April 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (16_supplem) , S96-S97
Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis
- 18 April 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (16_supplem) , S96-S97
Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis
- Open Access
- 17 October 2022
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (08) , 806-811
Characterization of the nigroestriatal system in a sample of patients with amyotrophic lateral sclerosis
Background The coexistence of amyotrophic lateral sclerosis (ALS) with clinical forms of Parkinson disease (PD), although uncommon, is found to a greater degree than one would expect by chance. The pathological mechanisms of ALS and PD are still not fully understood, and the coexistence of these two diseases suggests that they could share mechanisms in common. Objective Here we present a sample of patients with clinically definitive or probable ALS who were evaluated with single-photon emission computed tomography SPECT/TRODAT and compared with non-ALS controls. Methods Patients with clinically definite or probable ALS were assessed with the amyotrophic lateral sclerosis functional rating scale (ALSFRS) to define severity and had their demographic data collected. The TRODAT results of patients with ALS were compared with those of patients with a diagnosis of PD with less than 10 years of duration, and with patients with a diagnosis of others movement disorders not associated with neurodegenerative diseases. Results A total of 75% of patients with ALS had TRODAT results below the levels considered normal; that was also true for 25% of the patients in the control group without neurodegenerative disease, and for 100% of the patients in the PD group. A statistically significant difference was found between patients with ALS and the control group without neurodegenerative disease in the TRODAT values < 0.05. Conclusions Our study fits with the neuropathological and functional evidence that demonstrates the existence of nigrostriatal dysfunction in patients with ALS. Further research to better understand the role of these changes in the pathophysiological process of ALS needs to be performed.
- 17 October 2022
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (08) , 806-811
Open AccessCharacterization of the nigroestriatal system in a sample of patients with amyotrophic lateral sclerosis
Background The coexistence of amyotrophic lateral sclerosis (ALS) with clinical forms of Parkinson disease (PD), although uncommon, is found to a greater degree than one would expect by chance. The pathological mechanisms of ALS and PD are still not fully understood, and the coexistence of these two diseases suggests that they could share mechanisms in common. Objective Here we present a sample of patients with clinically definitive or probable ALS who were evaluated with single-photon emission computed tomography SPECT/TRODAT and compared with non-ALS controls. Methods Patients with clinically definite or probable ALS were assessed with the amyotrophic lateral sclerosis functional rating scale (ALSFRS) to define severity and had their demographic data collected. The TRODAT results of patients with ALS were compared with those of patients with a diagnosis of PD with less than 10 years of duration, and with patients with a diagnosis of others movement disorders not associated with neurodegenerative diseases. Results A total of 75% of patients with ALS had TRODAT results below the levels considered normal; that was also true for 25% of the patients in the control group without neurodegenerative disease, and for 100% of the patients in the PD group. A statistically significant difference was found between patients with ALS and the control group without neurodegenerative disease in the TRODAT values < 0.05. Conclusions Our study fits with the neuropathological and functional evidence that demonstrates the existence of nigrostriatal dysfunction in patients with ALS. Further research to better understand the role of these changes in the pathophysiological process of ALS needs to be performed.
- Open Access
- 1 October 2022
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (10) , 1075-1076
The whistle-smile reflex: a missed sign
In this paper, we present a historical review of the whistle-smile reflex, a semiological sign missed in the literature and clinical practice.
- 1 October 2022
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (10) , 1075-1076
Open AccessThe whistle-smile reflex: a missed sign
In this paper, we present a historical review of the whistle-smile reflex, a semiological sign missed in the literature and clinical practice.
- Open Access
- 1 November 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (11) , 737
Anti-Ri autoimmune encephalitis associated with breast cancer
- 1 November 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (11) , 737
Open AccessAnti-Ri autoimmune encephalitis associated with breast cancer
- 14 September 2020
- Published by BMJ in Practical Neurology
- Vol. 20 (6) , 472-473
The medial hamstring (L5) reflex
- 14 September 2020
- Published by BMJ in Practical Neurology
- Vol. 20 (6) , 472-473
The medial hamstring (L5) reflex
- 28 April 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 94 (17) , e1870-e1871
Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis
- 28 April 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 94 (17) , e1870-e1871
Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis